Investing.com - Gilead reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Gilead announced earnings per share of $2.12 on revenue of $6.59B. Analysts polled by Investing.com EPS of $1.8 on revenue of $6.28B.
Gilead 's are down 9% and is trading at $61.00 , still down 16.95% from its 52 week high of $74.12 set on Thursday, December 30, 2021.
Gilead shares lost 0.91% to trade at $61.00 in after-hours trade the report.
Gilead follows other major Healthcare sector earnings this month
Gilead's report follows an earnings beat by UnitedHealth on Thursday, April 14, 2022, who reported EPS of $5.49 on revenue of $80.15B, EPS of $5.36 on revenue of $78.73B.
J&J had beat expectations on Tuesday, April 19, 2022 with first quarter EPS of $2.67 on revenue of $23.43B, for EPS of $2.59 on revenue of $23.62B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar